Hugin Family Foundation Inc.

The Hugin Family Foundation is a tightly controlled family foundation with no public application process. Its website (hugin.org) displays only a single placeholder image, and there are no published guidelines, open RFPs, or online submission portals of any kind. Every grant in the foundation's documented history flows from the direct relationships and personal biography of Robert J. Hugin.

Robert Hugin is the essential gateway. He served as CEO and then Executive Chairman of Celgene Corporation through its $74 billion acquisition by Bristol-Myers Squibb in November 2019 — the event that capitalized the foundation's current ~$20 million asset base, with $17.7 million in net investment income and $13.1 million in contributions flowing in that year alone. He is a charter trustee of Princeton University, served 14+ years on the Darden School Foundation Board at the University of Virginia (receiving UVA Darden's highest alumni award in April 2025), sits on the board of the Parker Institute for Cancer Immunotherapy, advises the Focused Ultrasound Foundation, and chairs the Garden State Initiative in New Jersey. These affiliations are not incidental biographies — they are the direct explanation for which organizations receive funding. UVA has received $1,865,195 across four grants. Georgetown received $260,000 in a single grant. Garden State Initiative received $140,000 across two grants. Parker Institute received $100,000.

First-time applicants must internalize one reality: cold outreach to this foundation is very unlikely to succeed. The foundation's internal flag as "preselected only" accurately reflects how grants are actually made — at the discretion of the family, based on existing relationships or compelling personal introductions. There is no review committee outside the family, no open grant cycle, and no communicated application window.

The viable path is a warm introduction through one of Robert Hugin's board networks. If your organization has any institutional connection to UVA Darden, Princeton, the Parker Institute, the Focused Ultrasound Foundation, or the Garden State Initiative, identify any mutual contacts who can bridge that introduction. Sharon Melvin, the foundation's paid Administrator, handles day-to-day operations and can be reached at (908) 273-8610. A brief phone call to test whether an inquiry is welcome — before preparing any written materials — is strongly advised.

Proposals should be concise (two pages maximum for a first inquiry) and must explicitly tie the organization's work to Robert Hugin's known priorities: cancer immunotherapy, New Jersey civic life and economic policy, higher education access, military service, or community resilience in Summit and coastal New Jersey.

The Hugin Family Foundation's giving history is sharply variable, reflecting the family's discretionary, relationship-first approach rather than a formulaic payout strategy. Total annual charitable disbursements have ranged from a low of $636,962 (FY2018) to a peak of $3,523,967 (FY2023), with most active years between $600,000 and $3.1 million. FY2024 disbursements fell to $698,877 across 16 grants — the lowest annual total since FY2018 — likely marking the close of a multi-year UVA commitment.

The University of Virginia is by far the foundation's dominant grantee, having received $1,865,195 across four separate grants, representing approximately 57% of the total disclosed grantee pool in the 33-grant database. The single largest gift exceeded $1.4 million in a single filing year. Beyond UVA: Georgetown University received $260,000 in one grant; Garden State Initiative received $140,000 across two grants; Parker Institute for Cancer Immunotherapy received $100,000. These four recipients together account for roughly 73% of all documented giving.

Grant sizes span an extraordinary range: from $50 (a nominal Princeton University gift) and $100 (Summit FMBA Local 54) on the low end, to individual gifts exceeding $1 million at the high end. The arithmetic average across 33 documented grants is approximately $98,263, but this is severely skewed by the UVA concentration; the median grant is approximately $5,000. Small local grants ($50–$5,000) to Summit, NJ and Bay Head, NJ organizations — police and fire auxiliary funds, faith communities, first-aid squads — are routine and appear to reflect ongoing community presence rather than strategic philanthropy.

By focus area: higher education commands the largest share of cumulative dollars, an estimated 65–70% (UVA, Georgetown, Darden School, Lehigh University, Weill Cornell, Princeton). New Jersey civic and community organizations account for approximately 12–15% (Garden State Initiative, local emergency services, Summit United Methodist Church). Biomedical and cancer research (Parker Institute, Weill Cornell Medical College) represents roughly 5–8%. Military and veterans (Marine Corps University Foundation, $60,383 in FY2024) and youth development (Educare DC, Scholarship Fund for Inner City Children) each appear consistently at small-grant levels.

Geographically, 18 of 33 documented grants flow to New Jersey organizations. Virginia (UVA and Darden), New York, Washington DC, Florida, California, Iowa, and Pennsylvania follow. In FY2024, the three largest known grants were Family Promise ($257,950), Donors Trust ($100,000), and Marine Corps University Foundation ($60,383).

All five peer foundations hold between $19.9 million and $20.1 million in assets and share the same NTEE classification (T20, Private Grantmaking Foundations). None maintain public-facing websites or disclosed application processes, placing Hugin firmly in the invitation-only tier of similarly sized private foundations.

The Hugin Family Foundation stands out in two important ways. First, its annual giving is unusually volatile — from $637,000 to $3.5 million in a single year — a pattern typical of foundations making concentrated multi-year institutional pledges rather than steady formulaic distributions. Most comparable $20M foundations distribute 5–7% of assets annually ($1.0–1.4M); Hugin has in some years exceeded 15% of assets in total giving and in others disbursed as little as 3.2%. Second, Hugin is the only foundation in this peer group with a clearly documented biography-driven giving profile tied to a prominent public figure (Robert J. Hugin, former Celgene CEO and NJ civic leader), making its priorities more legible to researchers while simultaneously reinforcing its de-facto invitation-only character for applicants without a personal introduction.

The most significant recent development involving the foundation's principal is Robert J. Hugin receiving the Charles C. Abbott Award from UVA Darden on April 28, 2025 — the school's highest alumni honor — recognizing over 14 years on the Darden School Foundation Board and major philanthropic contributions to student access, faculty support, and capital campaigns. This honor likely signals continued or renewed giving to UVA, making UVA-affiliated organizations especially well positioned for the near term.

In FY2024, the foundation made 16 grants totaling $698,877. The three largest disclosed grants were Family Promise at $257,950 (a national nonprofit providing housing stability services — a category new to the foundation's grantee list), Donors Trust at $100,000 (a vehicle for center-right philanthropy, reflecting Robert Hugin's expanding NJ civic role), and Marine Corps University Foundation at $60,383. The FY2024 total marks a sharp pullback from FY2023's $3,523,967 across 14 grants.

The dramatic FY2023 disbursement spike ($3.5M) was the foundation's highest in recent years and likely reflects one or more large commitments tied to Robert Hugin's culminating service on the Darden School Foundation Board. The foundation itself was substantially recapitalized in FY2019, when net investment income of $17.7 million and contributions of $13.1 million grew assets from $3.4 million to $21.1 million — coinciding with the Bristol-Myers Squibb acquisition of Celgene, which closed in November 2019.

No leadership changes, new program announcements, or formal press releases from the foundation were identified in searches conducted for this report beyond the UVA alumni award coverage.

Because the Hugin Family Foundation does not accept unsolicited applications, all practical tips derive from documented giving patterns and Robert Hugin's professional biography rather than any published guidelines.

Timing. The foundation follows no disclosed grant cycle. Historical 990 filings show grants made across calendar quarters. Approaching Administrator Sharon Melvin in early Q1 (January–February) or early Q3 (July–August) — when many family foundations conduct informal giving reviews — is a reasonable starting point. Do not wait for a publicly announced deadline that will never appear.

Connection is the only credential. Every major grant in the foundation's history links directly to Robert Hugin's personal network. UVA Darden (14+ years on the Foundation Board), Parker Institute (current board seat), Garden State Initiative (chairman), and the Marine Corps University Foundation all received grants that map precisely to his biographical involvement. If your organization cannot identify a specific, genuine connection to the Hugin family or their known networks, the probability of success is very low regardless of mission quality.

Frame around the Hugin identity. An opening inquiry should explicitly name, where truthful, any intersection with Celgene's cancer legacy, UVA or Princeton alumni communities, NJ public policy work, support for military and veterans, or early childhood education. Avoid generic language like "general operating support" with no personal thread. The family responds to organizations that are part of their world, not organizations they have never encountered.

Small NJ community grants. Note that organizations like Summit's police and fire auxiliaries receive grants as low as $50–$250. These gifts appear to flow from ongoing community presence and personal relationships in Summit, NJ — not competitive applications. Do not submit proposals to obtain this type of support; it is not available through a formal channel.

Mistakes to avoid. Submitting a full unsolicited proposal without prior contact; sending mass-template letters of inquiry; approaching through an intermediary who has no actual relationship with the Hugin family; and presenting large multi-year budget requests without first establishing a relationship.

Cancer research and biomedical organizations specifically. Explicitly reference Robert Hugin's role at Celgene and his current Parker Institute board membership. Position your work as a natural continuation of the immunotherapy-focused giving he has championed. A one-page briefing connecting your science to approved FDA cancer immunotherapy approaches will resonate far more than a standard program description.